E3 PreliminaryPreliminaryPEM not requiredMethods-PaperPeer-reviewedMachine draft
Use of the polymerase chain reaction to detect Toxoplasma gondii in human blood samples.
Ho-Yen, D O, Joss, A W, Balfour, A H et al. · Journal of clinical pathology · 1992 · DOI
Quick Summary
This study tested a laboratory technique called PCR to detect a parasite called Toxoplasma gondii in blood samples. Researchers found that PCR was fast, accurate, and sensitive enough to detect even very small amounts of the parasite. The test helped doctors decide whether patients needed treatment, especially those with weakened immune systems.
Why It Matters
While this study addresses Toxoplasma, not ME/CFS directly, it is relevant because some ME/CFS researchers have investigated chronic latent infections as potential cofactors in disease pathogenesis. Development of sensitive molecular detection methods for intracellular pathogens may help future research clarify whether organisms like Toxoplasma contribute to ME/CFS symptoms or complicate clinical presentation.
Observed Findings
- PCR detected 8–16 parasites in one spiked experiment and 1–4 parasites in eight separate experiments, demonstrating high sensitivity.
- All nine unspiked control samples (without added parasites) were PCR-negative, showing high specificity.
- In 34 clinical samples, PCR results concorded with animal culture in 33 of 34 cases (97% agreement).
- Three of four immunocompromised patients with reactivated infection had positive PCR results.
- Negative PCR in nine patients with persisting IgM suggested absence of active parasitemia despite past or present antibodies.
Inferred Conclusions
- Nested PCR targeting the B1 gene is a rapid, sensitive, and specific method for detecting Toxoplasma parasitemia in blood.
- PCR results help distinguish active from past infection and guide treatment decisions in immunocompromised patients.
- Negative PCR in patients with IgM seropositivity suggests latent rather than active infection.
Remaining Questions
- What is the clinical significance of PCR positivity versus serology in predicting fetal infection or maternal-to-fetal transmission risk?
- How does PCR sensitivity vary with parasite burden thresholds clinically relevant to different patient populations?
What This Study Does Not Prove
This study does not prove that Toxoplasma causes or contributes to ME/CFS, nor does it establish any link between this parasite and myalgic encephalomyelitis. It is a technical validation study of a diagnostic method, not an epidemiological or mechanistic investigation of infection in ME/CFS populations.
Tags
Biomarker:Blood Biomarker
Method Flag:No ControlsSmall SampleExploratory Only
Metadata
- DOI
- 10.1136/jcp.45.10.910
- PMID
- 1430262
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →